What is Organogenesis Holdings Inc.'s preferred stock?

Organogenesis Holdings Inc. (ORGO) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Organogenesis Holdings Inc. ORGO Preferred Stock

Preferred Stock at other companies

IAR

Integra LifeSciencesIART

$0—

ArtivionAORT

$0—

LeMaitre VascularLMAT

$0—

AngioDynamicsANGO

$0—

AdaptHealthAHCO

$1K0.0%

UFP TechnologiesUFPT

$0—

Other financials

Income statement

See full

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

See full

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

See full

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

See full

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

See full

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

See full

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s preferred stock?: Organogenesis Holdings Inc. (ORGO) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.